ChemFuture PharmaTech

ChemFuture PharmaTech is a specialized Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) that provides high-end medicinal chemistry and process R&D services. Established in 2010 and based in Wuxi, China, the company focuses on the discovery and development of small molecule therapeutics, offering expertise in custom synthesis, lead optimization, and scale-up manufacturing. In January 2021, ChemFuture was acquired by Pharmaron, a global leader in life science R&D services, to further strengthen Pharmaron's integrated chemistry platform. The company is recognized for its ability to handle complex synthetic chemistry challenges and its commitment to international quality standards. ChemFuture serves a diverse global clientele, ranging from virtual biotech startups to large multinational pharmaceutical corporations.